Compounded medications are prepared by licensed pharmacies to meet the specific needs of individual patients. These medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. However, they are made in accordance with strict regulatory guidelines. If your clinician determines that a compounded medication is clinically appropriate for you, please be aware that it is not an FDA-approved product.
Ozempic®, Wegovy®, and Rybelsus® are the only FDA-approved products containing semaglutide produced by Novo Nordisk, Inc., while Zepbound® and Mounjaro® are the only FDA-approved products containing tirzepatide produced by Lilly USA LLC.